Top Markets
Coin of the day
YD Bio Limited Ordinary Shares YD Bio Limited Ordinary Shares

YD Bio Limited Ordinary Shares

YDES
Rank in Stocks #19448
Breeze Holdings Acquisition Corp. is a clinical-stage biopharmaceutical company... Breeze Holdings Acquisition Corp. is a clinical-stage biopharmaceutical company based in Taipei, Taiwan. The firm concentrates its efforts on developing medical diagnostics for cancer prevention and creating exosome-based therapeutics, both of which aim to revolutionize treatment options for diseases with significant unmet medical needs.
Share Price
$2.28
Last synced: 2026-07-31
Market Cap
$161.59M
Change (1 day)
3.70%
Change (1 year)
-82.92%
Country
TW
Trade YD Bio Limited Ordinary Shares (YDES)

Category

Operating Margin for YD Bio Limited Ordinary Shares (YDES)
Operating Margin as of 2026 TTM: 0.00%
According to YD Bio Limited Ordinary Shares latest financial reports and stock price the company's current Operating Margin (TTM) is 0.00%. At the end of 2026 the company had an Operating Margin of 0.00%.
Operating Margin history for YD Bio Limited Ordinary Shares from 2026 to 2026
Operating Margin at the end of each year
Year Operating Margin Change
Not enough data for the provided dates.
Operating Margin for similar companies or competitors
Company Operating Margin Operating Margin Difference Country
38.59% -
US
28.81% -
NL
-149.01% -
US
25.72% -
AU
0.00% -
CH
What is a company's Operating Margin?
The operating margin is a key indicator to assess the profitability of a company. Higher operating margins are generaly better as they show that a company is able to sell its products or services for much more than their production costs. The operating margin is calculated by dividing a company's earnings by its revenue.